Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Ultravate
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
Trade names | Ultravate, Lexette, Bryhali |
Other names | Halobetasol propionate, halobetasol propionate (USAN US) |
AHFS/Drugs.com | Professional Drug Facts |
MedlinePlus | a601060 |
Routes of administration |
Topical |
Drug class | Corticosteroid; Glucocorticoid |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.211.977 |
Chemical and physical data | |
Formula | C25H31ClF2O5 |
Molar mass | 484.96 g·mol−1 |
3D model (JSmol) | |
| |
|
Ulobetasol propionate, also known as halobetasol propionate and sold under the brand name Ultravate among others, is a synthetic glucocorticoid corticosteroid and a corticosteroid ester.
It was patented in 1975 and approved for medical use in 1990.
External links
- "Halobetasol propionate". Drug Information Portal. U.S. National Library of Medicine.